
APURES CO., LTD. — Investor Relations & Filings
APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 기타시장안내 (상장폐지 절차 진행 안내) | 2026-05-07 | Korean | |
| 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) | 2026-05-07 | Korean | |
| 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | |
| 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | |
| 정기주주총회결과 | 2026-03-31 | Korean | |
| 지정자문인선임계약의해지 | 2026-03-24 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42656701 | 기타시장안내 (상장폐지 절차 진행 안내) | 2026-05-07 | Korean | ||
| 42656667 | 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) | 2026-05-07 | Korean | ||
| 34380654 | 주권매매거래정지기간변경 (상장폐지사유 발생) | 2026-04-13 | Korean | ||
| 34379242 | 기타시장안내 (상장폐지 관련) | 2026-04-13 | Korean | ||
| 33116515 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33020169 | 지정자문인선임계약의해지 | 2026-03-24 | Korean | ||
| 33020113 | 주권매매거래정지기간변경 (지정자문인 계약해지) | 2026-03-24 | Korean | ||
| 33020111 | 기타시장안내 (지정자문인 계약해지) | 2026-03-24 | Korean | ||
| 33013934 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 33012105 | 주권매매거래정지 (상장폐지사유발생) | 2026-03-23 | Korean | ||
| 33012103 | 감사보고서제출 | 2026-03-23 | Korean | ||
| 33012096 | 기타시장안내 (상장폐지 관련) | 2026-03-23 | Korean | ||
| 33012074 | [기재정정]주주총회소집결의 | 2026-03-23 | Korean | ||
| 32953912 | 주주총회소집공고 | 2026-03-16 | Korean | ||
| 32921521 | 주주총회소집결의 | 2026-03-10 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
APURES CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15871/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15871 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15871 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15871 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15871}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for APURES CO., LTD. (id: 15871)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.